Mckesson (MCK) EBITDA (2009 - 2026)
Mckesson (MCK) posted quarterly EBITDA of $2.2 billion for Q1 2026, up 35.14% year-over-year from $1.6 billion in Q1 2025, and up 32.8% quarter-over-quarter from $1.6 billion in Q4 2025.
Mckesson (MCK) EBITDA (2009 - 2026) Analysis & Trends
Mckesson (MCK) has reported EBITDA for 18 consecutive years, with $2.2 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA rose 35.14% year-over-year to $2.2 billion; the TTM figure through Mar 2026 stood at $6.2 billion (up 40.48% YoY), while the FY2026 annual figure was $6.2 billion, up 40.48% from the prior year.
- EBITDA improved to $2.2 billion in Q1 2026 per MCK's latest filing, from $1.6 billion in the prior quarter.
- Across five years, EBITDA topped out at $2.2 billion in Q1 2026 and bottomed at $578.0 million in Q3 2024.
- Historically, EBITDA has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2023.
- Annual changes were most pronounced in 2022 — EBITDA surged 316.44% — and 2023, when it sank 48.27%.
- Mckesson's EBITDA stood at $1.2 billion in 2022, then sank by 48.27% to $642.0 million in 2023, then surged by 90.65% to $1.2 billion in 2024, then surged by 32.27% to $1.6 billion in 2025, then surged by 32.8% to $2.2 billion in 2026.
- Business Quant data shows MCK's EBITDA at $2.2 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 100.02 Bn | 94.85 Bn | 3.69 Bn | 1.32 Bn |
| 2 | Cencora | 60.88 Bn | 58.06 Bn | 3.61 Bn | 1.27 Bn |
| 3 | Cardinal Health | 54.14 Bn | 49.29 Bn | 2.56 Bn | 729.00 Mn |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | 171.00 Mn |
| 5 | Akso Health | 737.16 Mn | 736.96 Mn | - | - |
| 6 | Edap Tms | 159.12 Mn | 137.58 Mn | 7.34 Mn | -8.03 Mn |
| 7 | Accendra Health | 100.85 Mn | 93.20 Mn | 263.41 Mn | -35.15 Mn |
| 8 | 111 | 32.10 Mn | -26.65 Mn | 18.18 Mn | -2.88 Mn |
| 9 | Cosmos Health | 12.73 Mn | 10.29 Mn | 1.51 Mn | -2.81 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | -109,860.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.32 Bn |
| Mar 31, 2026 | 2.15 Bn |
| Dec 31, 2025 | 1.62 Bn |
| Sep 30, 2025 | 1.41 Bn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 1.59 Bn |
| Dec 31, 2024 | 1.22 Bn |
| Sep 30, 2024 | 578.00 Mn |
| Jun 30, 2024 | 1.03 Bn |
| Mar 31, 2024 | 1.22 Bn |
| Dec 31, 2023 | 642.00 Mn |
| Sep 30, 2023 | 951.00 Mn |
| Jun 30, 2023 | 1.10 Bn |
| Mar 31, 2023 | 980.00 Mn |
| Dec 31, 2022 | 1.24 Bn |
| Sep 30, 2022 | 1.12 Bn |
| Jun 30, 2022 | 1.04 Bn |
| Mar 31, 2022 | 633.00 Mn |
| Dec 31, 2021 | 298.00 Mn |
| Sep 30, 2021 | 539.00 Mn |